Contact Us | Share
Purdue Pharma L.P. is a pharmaceutical company committed to improving patients' lives and serving the healthcare community.
Purdue Pharma L.P. is a privately held pharmaceutical company founded by physicians more than 60 years ago. We are committed to improving patients’ lives in meaningful ways by providing safe and effective therapies along with educational tools that support their proper use.
Purdue Pharma L.P. is a member company of a network of independent associated companies which are engaged in the research, development, production, and marketing of prescription and over-the-counter medicines and healthcare products. Distinguished by our pioneering research, products, and medical programs directed toward alleviating pain, Purdue is an industry leader in pain medication research and is introducing important products to address other therapeutic areas, including sleep and gastrointestinal disorders.
We are pursuing a promising pipeline of new medications through internal research & development and strategic industry partnerships. At Purdue, we embrace our mission to find, develop, and introduce innovative medicines that meet the evolving needs of healthcare professionals, patients, and caregivers.
Copyright ©2013 Purdue Pharma L.P., Stamford, CT 06901-3431.
Intended for residents of the United States only.
Purdue, as used in this site, refers to Purdue Pharma L.P.,
Purdue Products L.P., and their independent associated United States companies.
Thank you! The page has been sent.
There was a problem sending this page, please try again.
Dr. John Purdue Gray and George Frederick Bingham start The Purdue Frederick Company on Manhattan's Lower East Side.
Drs. Raymond and Mortimer Sackler purchase The Purdue Frederick Company and move the company to Christopher Street, New York City.
Senokot® Laxatives are introduced in U.S.
Cerumenex® drops*, the first liquid agent for removing excess earwax, introduced.
*Product no longer available.
Arthropan® (choline salicylate) liquid* for the treatment of arthritis introduced.
*Product no longer available.
Company relocates to Yonkers, NY.
Betadine® broad-spectrum microbicides are acquired by Purdue.
Betadine® Surgical Scrub is used to decontaminate the Apollo lunar module after Neil Armstrong's moonwalk.
Contin® controlled drug-release system is developed.
Corporate headquarters relocates to South Norwalk, CT.
Manufacturing relocates to Totowa, NJ.
Trilisate® (choline salicylate) tablets* for the treatment of arthritis introduced.
*Product no longer available.
Corporate headquarters relocates to Norwalk, CT. The company's renovation of a former factory building won the Urban Land Institute Award for Excellence.
MS Contin® (morphine sulfate controlled-release) Tablets with patented Contin® system is launched. Click here for full Prescribing Information, including Boxed Warning.
Uniphyl® tablets* – the world's first oral theophylline designed for once-a-day use to control asthma – introduced.
*Product no longer available.
Purdue Pharma L.P. is formed.
Purdue establishes Partners Against Pain®, an alliance of patients, caregivers, and healthcare providers dedicated to pain management education and advocacy, to raise awareness of the importance of pain management.
OxyContin® (oxycodone HCI controlled-release) Tablets C-II are launched. Click here for full Prescribing Information, including Boxed Warning.
Purdue relocates to One Stamford Forum, a distinctive tiered office tower in Stamford, CT.
Purdue Pharmaceuticals L.P., a new manufacturing facility, is dedicated in Wilson, NC.
Purdue occupies new headquarters building for discovery research and non-clinical development in Cranbury, NJ.
Purdue develops Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS®) System.
Purdue Products L.P. is established and acquires Colace® Stool Softeners, Peri-Colace® Capsules, and Slow-Mag® Tablets.
Purdue establishes RxPATROL®, a collaborative effort between industry and law enforcement designed to collect, collate, analyze, and disseminate pharmacy theft information.
Purdue establishes In the Face of Pain®, an online pain advocacy toolkit, with pain-related information and resources to empower healthcare professionals, people with pain, and concerned individuals to take action.
Purdue licenses once-daily formulation of tramadol from Labopharm Inc. of Laval, Canada.
Radio frequency ID tags and color-shifting ink integrated into OxyContin® packaging.
Ryzolt® (tramadol hydrochloride extended-release tablets) is launched in U.S. Click here for Full Prescribing Information.
Purdue licenses zolpidem tartrate sublingual tablets from Transcept Pharmaceuticals, Inc.
Reformulation of OxyContin® (oxycodone HCl controlled-release) Tablets C-II is launched. Click here for full Prescribing Information, including Boxed Warning.
Rx Safety Matters website is launched.
Butrans® (buprenorphine) Transdermal System C-III is launched. Click here for full Prescribing Information, including Boxed Warning.
Intermezzo® (zolpidem tartrate sublingual tablets) is launched. Click here for full Prescribing Information.
